Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cloretazine: Phase I/II started

VION began a dose-escalation Phase I/II trial in 29 patients.

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE